Black Diamond Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $68k | 37k | 1.85 |
| 2025-03-31 | $85k | 55k | 1.55 |
| 2024-12-31 | $120k | 56k | 2.14 |
| 2024-09-30 | $213k | 49k | 4.35 |
| 2024-06-30 | $218k | 47k | 4.66 |
| 2024-03-31 | $2.3k | 449 | 5.07 |
| 2023-12-31 | $1.3k | 449 | 2.81 |
| 2023-09-30 | $1.3k | 449 | 2.87 |
| 2023-06-30 | $2.3k | 449 | 5.05 |
| 2022-03-31 | $81k | 29k | 2.79 |
| 2021-12-31 | $164k | 31k | 5.32 |
| 2021-09-30 | $266k | 31k | 8.47 |
| 2021-06-30 | $370k | 30k | 12.20 |
| 2021-03-31 | $444k | 18k | 24.25 |
| 2020-12-31 | $622k | 19k | 32.04 |
| 2020-09-30 | $514k | 17k | 30.20 |
| 2020-06-30 | $638k | 15k | 42.14 |
| 2020-03-31 | $301k | 12k | 24.96 |